▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | GreenCity | Italian Channel Awards | Italian Project Awards | ...
InnovationOpenLab

Saguaro Biosciences Secures $3M in Seed Funding to Transform Cell Biology Research

#Biotech--Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity ...

Business Wire

QUEBEC CITY: #Biotech--Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive grant funding. The funding round was led by AQC Capital and Anges Québec, featuring significant contributions from notable figures including Martin Leblanc, Co-Founder and Vice-Chairman of CellCarta Biosciences, alongside strategic investments from Investissement Quebec and Ville de Québec.

This investment will drive the commercial expansion of ChromaLive™, the groundbreaking reagent platform developed by Saguaro Biosciences, which enables time-sensitive imaging and AI-enabled analysis of cells. Already adopted by major pharmaceutical companies, ChromaLive™ empowers researchers to advance more effectively in the development of new therapies and breakthrough discoveries.

"Our mission to advance life science discoveries by illuminating the complexities of cell biology has never been more critical," said Louis Turcotte, CEO and Co-Founder of Saguaro Biosciences. "This funding will not only accelerate our technology's adoption but also allow the expansion of our portfolio, paving the way for transformative applications that contribute to building the future of human health."

Martin Leblanc, Co-Founder and Vice-Chairman of CellCarta Biosciences, and newly appointed Chairman of the Board of Saguaro Biosciences, brings a wealth of experience and an extensive network to the company. "The potential of ChromaLive™ to improve how we analyze cells and gain new insights into cell biology is very significant. I am thrilled to help steer Saguaro Biosciences towards becoming a global leader in its space," said Leblanc.

Kalthoum Bouacida, Partner at AQC Capital, shared her enthusiasm for their leading role in the funding round: “AQC Capital is thrilled to have led the Seed funding round for Saguaro Biosciences, a company that is setting new standards in life sciences innovation with its revolutionary ChromaLive™ platform. We are confident in Saguaro Biosciences’ vision and look forward to seeing their impact on the future of medical research and therapeutic discovery.”

Highlighting the sector’s strategic significance, Pierre Fitzgibbon, Minister of Economy, Innovation and Energy, Minister Responsible for Regional Economic Development and Minister Responsible for the Metropolis and the Montréal Region, commented: “We’re committed to stimulating private investment in the entire life sciences value chain as it is a strategic sector for our economy. By supporting SMEs in this field, we support innovation and showcase Québec expertise, both here and abroad.”

Bicha Ngo, President and CEO, Investissement Québec, also added: “Life sciences is a strategic growth industry, and Investissement Québec is proud to contribute to the emergence of new players like Saguaro. With the Impulsion PME program, young and innovative Québec companies have an additional source of funding to help them develop and advance new ideas, here and abroad.”

Félix Lavoie-Pérusse, Chief Commercial Officer and Co-Founder, finally commented: "We are proud to see such strong validation from the scientific and investment communities. Our technology not only accelerates the pace of scientific discoveries but also opens new avenues for enhancing human health."

About Saguaro Biosciences: Saguaro Biosciences is dedicated to advancing life sciences with innovative reagents for AI-enabled cell analysis. With its flagship product, ChromaLive™, the company provides researchers around the world with powerful tools to demystify cell biology, thereby accelerating the path to new discoveries and therapies.

About AQC Capital: AQC Capital manages two venture capital funds to support businesses in the startup phase. The fund invests in Quebec companies in all sectors that seek to bring innovation to global markets. AQC Capital teams up with Anges Québec, the largest angel investor network in the country, and together the groups bring smart capital to startups thanks to their experience and network.

About Anges Québec: As Canada's largest group of angel investors, Anges Québec has been supporting passionate, innovative entrepreneurs for 15 years. With over 200 members from diverse backgrounds, we have invested close to $149 million in over 200 Quebec technology companies, in partnership with the AQC Capital fund. We are proud to play a leading role in Quebec's venture capital industry, actively supporting local innovation.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

Axyon AI: Italian Artificial Intelligence for Finance applications

Axyon AI offers an AI platform specifically designed for asset management, with several interesting strengths for those approaching machine/deep learning…

Italian Artificial Intelligence tackles medical emergencies at sea

Mermaid-AI is a telehealth platform at sea based on a visor equipped with an AR, medical Artificial Intelligence algorithms, satellite communications…

Gyala: a new "Made in Italy" cybersecurity

With a proven track record in the defence field, Gyala now also brings its cybersecurity technologies to the wider enterprise audience

ITALIAN PROJECT AWARDS 2023: the best IT projects of the year, awarded

Now in its third edition, the initiative is targeted at the ICT professional world and honours projects based on innovative ideas and technologies, realised…

Most read

AHSG Announces Leadership Transition as CEO Mark Smith Joins Board of…

AHSG, a technology-driven, healthcare workforce solutions company, today announced Mark Smith will be stepping down at the end of June as Chief Executive…

Verituity Raises $18.8M to Accelerate its B2B and B2C Verified Payout…

Verituity, a leading provider of intelligent, verified payouts solutions, announced the successful close of an $18.8 million funding round led by Sandbox…

HubStar Launches H2O, a Revolutionary New Approach to Optimizing Occupancy…

HubStar, a leader in dynamic workplace management technology, today announced the launch of H2O, the first ever hybrid occupancy platform designed to…

SMILE Health 2024: CareQuest Innovation Partners and MATTER Announce Largest…

CareQuest Innovation Partners, a company focused on validating and scaling transformative solutions to improve overall health through oral health for…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!